Chemical Biology of Neurodegeneration: A Molecular Approach
John Wiley & Sons, 7 ago 2019 - 384 páginas
Bridges the gap between the chemistry of small molecule neuromodulators and the complex pattern of neurodegenerative disorders
Written by an experienced neurochemist, this book focuses on the main actors involved in neurodegenerative disorders at a molecular level, and places special emphasis on structural aspects and modes of action. Drawing on recent data on enzyme structure, mode of action, and inhibitor design, it describes?from a biochemical point of view?the six most important neurotransmitter systems and their constituent enzymes and receptors. Misfolding and aggregation of proteins within the brain is also covered. In addition, the book surveys a wide range of proven and prospective therapeutic agents that modulate key processes in the brain, from their chemical synthesis to their mode of action in model systems as well as in the patient.
Chemical Biology of Neurodegeneration: A Molecular Approach is presented in two parts. The first introduces the neurotransmitter systems and provides a general explanation of the synapse and a description of the main structures involved in neurotransmission that can be considered therapeutic targets for disorders of the central nervous system. The second part presents molecular and chemical aspects directly involved or affected in neurodegeneration, including the metabolism of neurotransmitters, enzymes processing neurotransmitters, protein misfolding, and therapeutic agents.
-Uses an interdisciplinary approach to bridge the gap between the basic biochemical events in a nerve cell and their neurological effects on the brain
-Places emphasis on the chemistry of small molecule modulators that are potential lead molecules for new drugs
-Covers six key neurotransmitter systems and their enzymes and receptors?dopaminergic, noradrenergic, serotonergic, cholinergic, GABAergic, and glutamatergic
Chemical Biology of Neurodegeneration: A Molecular Approach is a key resource for medicinal chemists, neurobiologists, neurochemists, biochemists, molecular biologists, and neurophysiologists.
Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
Otras ediciones - Ver todo
acetylcholine AChE activity adrenoceptor affinity agonist allosteric Alzheimer’s disease amino acid Biol C‐terminal calcium catalytic cell channel Chem choline cholinergic complex COMT conformation cortex crystal structure Curr cyan D2 receptor decarboxylase dimer disorders DOPA dopamine receptors dopaminergic drugs enzyme extracellular domains Figure function G Protein‐Coupled Receptors G‐protein G‐protein‐coupled GABAA receptors GABAergic gene Genet glutamate transporter GPCRs H‐bond hippocampus homology models human hydrogen bonds hydrophobic hydroxylase indicated on sequences inhibition inhibitors interactions involved ionotropic isoform kinase l‐DOPA ligand located loop magenta MAO‐B membrane metabolism Metabotropic glutamate receptors modulation molecular muscarinic receptors mutations natural variants Neurochem neurodegenerative neurodisorders neurons Neurosci neurotransmitter nicotinic receptors NMDA receptors noradrenergic norepinephrine orthosteric palmitoylation Parkinson’s disease pathways PDB ID Pharmacol pharmacology phosphorylation polymorphism presynaptic protein regulation residues role schizophrenia serotonergic serotonin transporter shown signaling studies substrate subtypes subunits synaptic target therapeutic transmembrane domains yellow tyrosine vesicles vesicular X‐ray structure